Search

So what exactly are you looking for? Let us know and we will help you find the best answer

Clear All

Jenburkt Pharmaceuticals Ltd.

  • NSE: JENBURPH

  • BSE: 524731

  • Q
  • V
  • T
  • Mid-range Performer
53.25/100

Quality Score

Medium Financial Strength
32.67/100

Valuation Score

Mid Valuation
55.22/100

Technical Score

Technically Neutral
Broker Average Rating

0.00

Broker Average Rating

MFI

62.17

MFI is mid-range

50Day SMA Rs

408.23 Rs

price crossed below SMA50 today

Quality score

53.25

Medium Financial Strength

30Day SMA Rs

395.71 Rs

Price above SMA 395.71

Broker Covering stock

0.00

None Broker Covering stock

Broker 6M Target upgrade

0.00

None Broker 6M Target upgrade

Broker 6M Target downgrade

0.00

None Broker 6M Target downgrade

Momentum score

55.22

Technically Neutral

Price to Book Ratio

2.35

Above industry Median

Broker Reports in 1Yr

0.00

None Broker Reports in 1Yr

TTM PE Ratio

11.51

Below industry Median

Broker 6M Reco upgrade

0.00

None Broker 6M Reco upgrade

RSI

52.35

RSI is mid-range

Net Profit Qtr Cr

1.01 Cr

Below industry Median

AVG Broker Target

0.00 %

No targets last year

Operating Revenues Qtr Cr

17.43 Cr

Below industry Median

MACD

-4.70

MACD below Center

Valuation score

32.67

Mid Valuation

MACD Signal Line

-10.12

MACD below Center

FII holding holding %

2.22 %

No change in FII holding

Promoter holding holding %

45.73 %

No change in Promoter holding

MF holding holding %

0.00 %

MF holding holding

Broker 6M Reco downgrade

0.00

None Broker 6M Reco downgrade

100Day SMA Rs

384.31 Rs

Price above SMA 384.31

Institutions holding holding %

2.22 %

No change in Institutions holding

AVG Broker Target

0.00 Rs

No targets last year

200Day SMA Rs

383.67 Rs

Price above SMA 383.67

Company is not Listed On NSE

    • 2020-09-12T09:27:39+00:00

    JENBURKT PHARMACEUTICALS LTD. - 524731 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    Intimation regarding loss of share certificate received from a shareholder of the Company.

    Read More
    • 2020-09-05T06:29:20+00:00

    JENBURKT PHARMACEUTICALS LTD. - 524731 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    Intimation regarding loss of share certificate by a shareholder

    Read More
    • 2020-09-02T13:04:16+00:00

    JENBURKT PHARMACEUTICALS LTD. - 524731 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

    Jenburkt Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here

    Read More
    • 2020-09-02T12:30:51+00:00

    JENBURKT PHARMACEUTICALS LTD. - 524731 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

    E-voting result and scrutinisers report for the 35th AGM of the company held on 1st September, 2020

    Read More
    • 2020-09-02T10:44:03+00:00

    JENBURKT PHARMACEUTICALS LTD. - 524731 - Proceedings Of The 35Th Annual General Meeting

    The 35th Annual General Meeting of the Company was held on 1st September, 2020, by Video conferencing / Other Audio Video means. Proceedings of the same is attached.

    Read More
    • 2020-08-20T12:25:08+00:00

    JENBURKT PHARMACEUTICALS LTD. - 524731 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    Intimation regarding loss of share certificate by a shareholder.

    Read More
    • 2020-08-11T04:09:13+00:00

    JENBURKT PHARMACEUTICALS LTD. - 524731 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    notice of loss of share certificate, details of which received from a shareholder.

    Read More
    • 2020-08-08T09:20:48+00:00

    JENBURKT PHARMACEUTICALS LTD. - 524731 - Announcement under Regulation 30 (LODR)-Newspaper Publication

    Newspaper publications of notice to shareholders regarding transfer of shares to IEPF.

    Read More
    • 2020-08-07T12:01:50+00:00

    JENBURKT PHARMACEUTICALS LTD. - 524731 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    Intimation about loss of share certificate by a shareholder

    Read More
    • 2020-08-05T11:04:08+00:00

    JENBURKT PHARMACEUTICALS LTD. - 524731 - Announcement under Regulation 30 (LODR)-Newspaper Publication

    newspaper publications dated 05.08.2020, of unaudited financial results of the Company for the quarter ended on 30.06.2020.

    Read More
    • 2020-08-05T10:45:02+00:00

    JENBURKT PHARMACEUTICALS LTD. - 524731 - Announcement under Regulation 30 (LODR)-Newspaper Publication

    Newspaper publication with details as required under Rule 20(4) of the Companies (Management and Administration) Rules, 2014, including e-mailing of annual report of the 35th Annual General Meeting of the Company.

    Read More
    • 2020-08-04T12:25:42+00:00

    JENBURKT PHARMACEUTICALS LTD. - 524731 - Reg. 34 (1) Annual Report

    Kindly find attached the soft copy of the Annual Report of the Company, pertaining to the financial year 2019-20.

    Read More
    • 2020-08-04T10:51:40+00:00

    JENBURKT PHARMACEUTICALS LTD. - 524731 - Unaudited Financial Results For The Quarter Ended On 30Th June, 2020

    Outcome of Board Meeting held today on 4th August, 2020 - Unaudited Financial results for the quarter ended on 30th June, 2020

    Read More
    • 2020-07-31T06:10:01+00:00

    JENBURKT PHARMACEUTICALS LTD. - 524731 - Fixation Of Book Closure And Record Date

    Announcement of Closure of register of members and share transfer book of the Company in connection with its ensuing 35th AGM and fixation of record date.

    Read More
    • 2020-07-28T07:06:34+00:00

    JENBURKT PHARMACEUTICALS LTD. - 524731 - Announcement under Regulation 30 (LODR)-Newspaper Publication

    Attachment of Advertisements in English and Marathi Newspapers regarding the ensuing board meeting to be held on 04th August, 2020, to consider and approve,amongst others, the unaudited financial statements for the quarter ended on 30th June, 2020.

    Read More
    • 2020-07-26T12:26:02+00:00

    JENBURKT PHARMACEUTICALS LTD. - 524731 - Board Meeting Intimation for Inter-Alia, Considering And Approving The Unaudited Financial Results Of The Company For The Quarter Ended On 30Th June, 2020.

    JENBURKT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2020 ,inter alia, to consider and approve the unaudited financial results of the Company for the quarter ended on 30th June, 2020.

    Read More
    • 2020-07-24T10:30:19+00:00

    JENBURKT PHARMACEUTICALS LTD. - 524731 - Announcement Under Regulation 30 Of SEBI (LODR) 2015 - Update Regarding New Product Launch

    With reference to our previous communication with regard to launch of product for treatment of mild to moderate Covid-19, please find attach further announcement.

    Read More
    • 2020-07-23T18:32:07+00:00

    JENBURKT PHARMACEUTICALS LTD. - 524731 - Financial Results For 31.03.2020.

    Kindly find enclosed disclosure of Related Party Transactions in the format specified under IND-AS, for the half year ended on 31*'' March, 2020, in accordance to Regulation 23(9) of SEBI (LODR) Regulations, 2015. We further report that no material related party transaction, in term of captioned regulation, was carried out during the financial year 2019-20.

    Read More
    • 2020-07-21T12:23:08+00:00

    JENBURKT PHARMACEUTICALS LTD. - 524731 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Certificate under regulation 74(5)of SEBI (DP) regulation, issued by RTA, for the quarter ended 30th June, 2020

    Read More
    • 2020-07-21T08:21:37+00:00

    JENBURKT PHARMACEUTICALS LTD. - 524731 - Closure of Trading Window

    Kindly take note of Closure of trading window for all trades in the securities of the Company, by the insiders.

    Read More

Jenburkt Pharmaceuticals Ltd. has declared 21 dividends since July 17, 2002.

In the past 12 months, the equity dividend amounts to Rs 8.10 per share.

At the current share price of Rs 396.50, this results in a dividend yield of 2.04%.

Ex-date Dividend Amount Dividend Type Record Date
2020-03-18 8.1 INTERIM 2020-03-19
2019-07-22 10.2 FINAL -
2018-07-23 6 FINAL -
2018-03-27 3 INTERIM 2018-03-28
2017-07-21 8.1 FINAL -
2016-07-19 0.9 FINAL -
2016-03-17 6.3 INTERIM 2016-03-18
2015-08-31 6.3 FINAL -
2014-09-03 5.1 FINAL -
2013-09-18 4.2 FINAL -
2012-07-23 3.5 FINAL -
2011-07-21 3.5 FINAL -
2010-07-21 3 FINAL -
2009-07-23 1.8 FINAL -
2008-07-23 1.25 FINAL -
2007-07-18 1.25 FINAL -
2006-07-20 1.25 FINAL -
2005-08-10 1 FINAL -
2004-07-21 0.7 FINAL -
2003-09-18 0.7 FINAL -
2002-07-17 0 FINAL -

Bonus History

Adani Ports & Special Economic Zone Ltd. has not announced any bonus since Jan 1, 2000.

Check out stocks with top dividend

Adani Ports & Special Economic Zone Ltd. has split the face value 1 time since Sept. 23, 2010. Adani Ports & Special Economic Zone Ltd. had last split the face value of its shares from Rs 10 to Rs 2 in 2016.The share has been quoting on an ex-split basis from Sept. 23, 2010.

Ex-date Old FV New FV Record Date
Sept. 23, 2010 10 FINAL Sept. 24, 2010